‘We aim to make early cancer detection accessible on a global scale’: Mirxes CEO

Q: How long will it take to read this news story?

The story "‘We aim to make early cancer detection accessible on a global scale’: Mirxes CEO" has 1926 words across 1 sentences, which will take approximately 9 - 17 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "‘We aim to make early cancer detection accessible on a global scale’: Mirxes CEO" was covered 14 hours ago by e27, a news publisher based in Singapore.

Q: How trustworthy is 'e27' news outlet?

e27 is a fully independent (privately-owned) news outlet established in 2006 that covers mostly startups and technology news. The outlet is headquartered in Singapore and publishes an average of 11 news stories per day. It's most recent story was published 11 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21719431</li><li>URL: https://beamstart.com/news/we-aim-to-make-early-17216200278938</li></ul>

e27 Logo e27 14h ago

‘We aim to make early cancer detection accessible on a global scale’: Mirxes CEO - e27

Quick Summary:

Mirxes Holding develops and commercialises non-invasive and affordable blood-based miRNA test kit products for the early detection of cancer and other diseases.

As part of our plans to bring accessible and affordable early cancer detection solutions to the ASEAN region, we signed a memorandum of understanding with PT ELION MEDIKA INDONESIA to bring RNA-powered early cancer detection tests to Indonesia.

In 2022, Mirxes jointly launched Southeast Asia’s first multi-centre study, Singapore Pulmonary Hypertension Early Detection with miRNA biomarkErs (SPHERE), with National University Heart Centre, Singapore (NUHCS) and National Heart Centre Singapore (NHCS) in a nationwide effort to manage the risk of pulmonary hypertension.